Gevorg Tamamyan։ We Are Looking for Champions Around the World

Phase 3 BATTMAN Trial Launches BOT/BAL in MSS or pMMR Metastatic Colorectal Cancer

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

2 New ES-SCLC Treatments Backed by EMA: A Major Shift in Care

Waleed Arafat: Final Days to Submit Abstracts for ISCO 2026

Pavankumar Anné: Excited to be joining OncoDaily for the upcoming ZS AI in Oncology session during ASCO

immunosarc II Trial: Sunitinib + Nivolumab in Advanced Clear Cell Sarcoma

Dr. Richard Goldberg on Why FDA Must Keep Pace as CRC Rises in Younger Adults

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

IMDC Risk Score Calculator (Metastatic RCC)

Classify metastatic Renal Cell Carcinoma (RCC) prognosis using IMDC (International Metastatic RCC Database Consortium) criteria.

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

Check if YES (risk factor), leave unchecked if NO

IMDC Risk Factors:

  • Time from diagnosis to treatment <1 year
  • Karnofsky Performance Status <80
  • Hemoglobin below LLN
  • Corrected calcium above ULN
  • Neutrophils above ULN
  • Platelets above ULN

Risk Categories:

  • Favorable: 0 risk factors
  • Intermediate: 1-2 risk factors
  • Poor: ≥3 risk factors

LLN = Lower Limit of Normal, ULN = Upper Limit of Normal